Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The primary aim of this research study is to determine whether titrated, patient-directed
transdermal patch NRT, based on smoking history and symptoms of nicotine withdrawal, improves
long-term rates of smoking cessation in patients motivated to quit smoking when compared to
patients using the standard transdermal NRT patch protocol. The following hypothesis will be
tested: CO-validated continuous abstinence rate at 52 weeks post target quit date will be
higher for the titrated, self-directed NRT group compared to the standard NRT treatment
group.